In tumours, as a response to DNA fragments, IFNα and IFNβ are secreted by cancer cells and DCs, resulting in the activation of the cGAS/STING pathway with the consequent T cell priming and anti-tumour activity [116]. Here, STING1 is linked to neoplasm.